Papers - SHIMABUKURO Michio
-
先天性リポイド副腎過形成古典型と複合型下垂体ホルモン分泌不全症を伴う患者の新規STAR遺伝子変異(Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency)
Higa Moritake, Zaha Akiko, Takushi Akiko, Morishima Nami, Majikina Toyofumi, Touma Takeshi, Shimabukuro Michio, Masuzaki Hiroaki, Honda Misa, Hasegawa Tomonobu
Human Genome Variation 8 1 of 4 - 4 of 4 2021.2
-
Ma E, Ohira T, Yasumura S, Nakano H, Eguchi E, Miyazaki M, Hosoya M, Sakai A, Takahashi A, Ohira H, Kazama J, Shimabukuro Michio, Yabe H, Maeda M, Ohto H, Kamiya K
Nutrients 13 ( 1 ) 168 2021.1
-
慢性腎臓病における腎疾患の原因別にみた貧血状態 福島CKDコホート研究(Status of Anemia According to Underlying Renal Disease in Chronic Kidney Disease: The Fukushima CKD Cohort)
Tanaka Kenichi, Saito Hirotaka, Iwasaki Tsuyoshi, Oda Akira, Watanabe Shuhei, Kanno Makoto, Kimura Hiroshi, Shimabukuro Michio, Asahi Koichi, Watanabe Tsuyoshi, Kazama Junichiro James
Annals of Clinical Epidemiology 3 ( 1 ) 27 - 35 2021.1
-
Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
Saito H, Tanaka K, Iwasaki T, Oda A, Watanabe S, Kanno M, Kimura H, Shimabukuro Michio, Asahi K, Watanabe T, Kazama JJ
Scientific Reports 11 ( 1 ) 1380 2021.1
-
Iwasaki Mariko, Kudo Akihiro, Asahi K, Machii Noritaka, Iseki K, Satoh H, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro Michio
Scientific Reports 11 ( 1 ) 716 2021.1
-
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group
BMJ Open Diabetes Research & Care 9 ( 1 ) e001787 2021.1
-
Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection Fraction
Maimaituxun G, Kusunose K, Yamada H, Fukuda D, Yagi S, Torii Y, Yamada N, Soeki T, Masuzaki H, Sata M, Shimabukuro Michio
Frontiers in Cardiovascular Medicine 7 607825 2021.1
-
慢性腎臓病における腎疾患の原因別にみた貧血状態 福島CKDコホート研究(Status of Anemia According to Underlying Renal Disease in Chronic Kidney Disease: The Fukushima CKD Cohort)
Tanaka Kenichi, Saito Hirotaka, Iwasaki Tsuyoshi, Oda Akira, Watanabe Shuhei, Kanno Makoto, Kimura Hiroshi, Shimabukuro Michio, Asahi Koichi, Watanabe Tsuyoshi, Kazama Junichiro James
Annals of Clinical Epidemiology 3 ( 1 ) 27 - 35 2021.1
-
慢性腎臓病における腎疾患の原因別にみた貧血状態 福島CKDコホート研究(Status of Anemia According to Underlying Renal Disease in Chronic Kidney Disease: The Fukushima CKD Cohort)
Tanaka Kenichi, Saito Hirotaka, Iwasaki Tsuyoshi, Oda Akira, Watanabe Shuhei, Kanno Makoto, Kimura Hiroshi, Shimabukuro Michio, Asahi Koichi, Watanabe Tsuyoshi, Kazama Junichiro James
Annals of Clinical Epidemiology 3 ( 1 ) 27 - 35 2021.1
-
Watanabe K, Higa M, Hasegawa Y, Kudo A, Allsopp RC, Willcox BJ, Willcox DC, Sata M, Masuzaki H, Shimabukuro M
Frontiers in nutrition 8 632422 2021（ ISSN:2296-861X ）
-
Watanabe K, Higa M, Hasegawa Y, Kudo A, Allsopp RC, Willcox BJ, Willcox DC, Sata M, Masuzaki H, Shimabukuro M
Frontiers in nutrition 8 632422 2021（ ISSN:2296-861X ）
-
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S
Journal of atherosclerosis and thrombosis 2020.12（ ISSN:1340-3478 ）
-
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial
Teragawa H, Morimoto T, Fujii Y, Ueda T, Sakuma M, Shimabukuro Michio, Arasaki O, Node K, Nomiyama T, Ueda S
Diabetes, Metabolic Syndrome and Obesity 13 4993 - 5001 2020.12
-
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial
Teragawa H, Morimoto T, Fujii Y, Ueda T, Sakuma M, Shimabukuro Michio, Arasaki O, Node K, Nomiyama T, Ueda S
Diabetes, Metabolic Syndrome and Obesity 13 4993 - 5001 2020.12
-
Tanaka A, Shimabukuro Michio, Machii Noritaka, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Ueda S, Higashi Y, Node K
Journal of Diabetes Investigation 11 ( 6 ) 1551 - 1563 2020.11（ ISSN:2040-1116 ）
-
心血管疾患を有する2型糖尿病患者におけるエンパグリフロジンの血管内皮機能に対する効果の二次解析 心血管高リスク糖尿病患者の血管内皮機能に対するエンパグリフロジンの効果のプラセボ対照二重盲検無作為化比較:多施設共同プラセボ対照二重盲検無作為化試験(Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial)
Tanaka Atsushi, Shimabukuro Michio, Machii Noritaka, Teragawa Hiroki, Okada Yosuke, Shima Kosuke R., Takamura Toshinari, Taguchi Isao, Hisauchi Itaru, Toyoda Shigeru, Matsuzawa Yasushi, Tomiyama Hirofumi, Yamaoka-Tojo Minako, Ueda Shinichiro, Higashi Yukihito, Node Koichi
Journal of Diabetes Investigation 11 ( 6 ) 1551 - 1563 2020.11（ ISSN:2040-1116 ）
-
心血管疾患を有する2型糖尿病患者におけるエンパグリフロジンの血管内皮機能に対する効果の二次解析 心血管高リスク糖尿病患者の血管内皮機能に対するエンパグリフロジンの効果のプラセボ対照二重盲検無作為化比較:多施設共同プラセボ対照二重盲検無作為化試験(Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial)
Tanaka Atsushi, Shimabukuro Michio, Machii Noritaka, Teragawa Hiroki, Okada Yosuke, Shima Kosuke R, Takamura Toshinari, Taguchi Isao, Hisauchi Itaru, Toyoda Shigeru, Matsuzawa Yasushi, Tomiyama Hirofumi, Yamaoka-Tojo Minako, Ueda Shinichiro, Higashi Yukihito, Node Koichi
Journal of Diabetes Investigation 11 ( 6 ) 1551 - 1563 2020.11（ ISSN:2040-1116 ）
-
心血管疾患を有する2型糖尿病患者におけるエンパグリフロジンの血管内皮機能に対する効果の二次解析 心血管高リスク糖尿病患者の血管内皮機能に対するエンパグリフロジンの効果のプラセボ対照二重盲検無作為化比較:多施設共同プラセボ対照二重盲検無作為化試験(Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial)
Tanaka Atsushi, Shimabukuro Michio, Machii Noritaka, Teragawa Hiroki, Okada Yosuke, Shima Kosuke R, Takamura Toshinari, Taguchi Isao, Hisauchi Itaru, Toyoda Shigeru, Matsuzawa Yasushi, Tomiyama Hirofumi, Yamaoka-Tojo Minako, Ueda Shinichiro, Higashi Yukihito, Node Koichi
Journal of Diabetes Investigation 11 ( 6 ) 1551 - 1563 2020.11（ ISSN:2040-1116 ）
-
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro Michio, Nomiyama T, Arasaki O, Node K, Ueda S
Frontiers in Endocrinology 11 575557 2020.9
-
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro Michio, Nomiyama T, Arasaki O, Node K, Ueda S
Frontiers in Endocrinology 11 575557 2020.9